Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy

被引:102
|
作者
Langendijk, JA
Slotman, BJ
van der Waal, I
Doornaert, P
Berkof, J
Leemans, CR
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Radiat Oncol, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Dept Maxillary Surg, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, Dept Clin Epidemiol & Biostat, Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Med Ctr, Dept Otolaryngol Head & Neck Surg, Amsterdam, Netherlands
关键词
head and neck carcinoma; radiotherapy; prognostic factors; overall treatment time;
D O I
10.1002/cncr.21340
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. The objective of this study was to define different prognostic groups with regard to locoregional control (LRC) derived from recursive partitioning analysis (RPA). METHODS. Eight hundred one patients with squamous cell head and neck carcinoma underwent with primary surgery and received postoperative radiotherapy. For the definition of prognostic groups, the method of classification and regression trees was performed, including a large number of well known prognostic factors. RESULTS. The final model was composed of six prognostic factors for LRC, resulting in seven terminal nodes. RPA Class I (intermediate risk) consisted of 381 patients who had no N3 lymph nodes, free surgical margins (> 5 mm), and no extranodal spread (ENS). RPA Class 11 (high risk) consisted of 189 patients who had 1 positive lymph node with ENS or had T1, T2, or T4 tumors with close or positive surgical margins. RPA Class III (very high risk) consisted of 231 patients who had a N3 neck, 2 positive lymph nodes with ENS, or a T3 tumor with close or positive surgical margins. The 5-year LRC rate was 88%, 73% and 58%, in RPA Class 1, 11, and III, respectively (P < 0.0001). The hazard ratio (HR) relative to RPA Class I was 2.3 (95% confidence interval [95%CI], 1.5-3.6) for RPA Class II and 4.2 (95%CI, 2.8-6.1) for RPA Class III. CONCLUSIONS. The RPA classification scheme studied allowed for the clear definition of three prognostic groups with regard to LRC and OS. These groups may be useful in the design of future prospective, randomized studies investigating new treatment modalities.
引用
收藏
页码:1408 / 1417
页数:10
相关论文
共 50 条
  • [1] Multicenter validation of recursive partitioning analysis classification for patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy
    Jonkman, Anja
    Kaanders, Johannes H. A. M.
    Terhaard, Chris H. J.
    Hoebers, Frank J. P.
    van den Ende, Piet L. A.
    Wijers, Oda B.
    Verhoef, Lia C. G.
    de Jong, Martin A.
    Leemans, C. Rene
    Langendijk, Johannes A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (01): : 119 - 125
  • [2] External validation of a risk group defined by recursive partitioning analysis in patients with head and neck carcinoma treated with surgery and postoperative radiotherapy
    Leon, Xavier
    Lopez, Montserrat
    Pineiro, Zenaida
    Langendijk, Johannes A.
    Leemans, Charles R.
    Quer, Miquel
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2007, 29 (09): : 815 - 821
  • [3] Recursive partitioning analysis in the postoperative setting in squamous cell head and neck cancer: Validation of risk group definition in a multicenter study of the Dutch head and neck cooperative group
    Jonkman, A.
    Terhaard, H.
    Kaanders, J.
    Hoebers, F.
    van den Ende, P.
    Wijers, O.
    Verhoef, L.
    de Jong, M.
    Leemans, C.
    Langendijk, A.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S130 - S130
  • [4] Recursive partitioning analysis in the postoperative setting in squamous cell head and neck cancer: Validation of risk group definition in the EORTC 22931 database
    Langendijk, Johannes A.
    Bogaerts, Jan
    Leemans, Charles R.
    Bernier, Jacques
    ANNALS OF ONCOLOGY, 2006, 17 : 179 - 180
  • [5] Risk-group Classification by Recursive Partitioning Analysis of Patients Affected by Oligometastatic Renal Cancer Treated with Stereotactic Radiotherapy
    Franzese, C.
    Navarria, P.
    Bellu, L.
    Marzo, M. A.
    Clerici, E.
    Badalamenti, M.
    Baldaccini, D.
    Franceschini, D.
    Comito, T.
    Teriaca, A.
    D'agostino, G.
    Reggiori, G.
    Tomatis, S.
    Scorsetti, M.
    CLINICAL ONCOLOGY, 2022, 34 (06) : 379 - 385
  • [6] Postoperative Radiotherapy for Squamous Cell Carcinoma of the Head and Neck
    Mendenhall, William M.
    Hinerman, Russell W.
    Amdur, Robert J.
    Malyapa, Robert S.
    Lansford, Christopher D.
    Werning, John W.
    Villaret, Douglas B.
    CLINICAL MEDICINE & RESEARCH, 2006, 4 (03) : 200 - 208
  • [7] Postoperative radiotherapy for high-risk head and neck squamous cell carcinoma
    Hamamoto, Y.
    Tsuruoka, S.
    Takata, N.
    Ishikawa, H.
    Nagasaki, K.
    Mochizuki, T.
    RADIOTHERAPY AND ONCOLOGY, 2019, 141 : S55 - S55
  • [8] Cell kinetics analysis in patients affected by squamous cell carcinoma of the head and neck treated with primary surgery and adjuvant radiotherapy
    Corvò, R
    Margarino, G
    Sanguineti, G
    Geido, E
    Scala, M
    Mereu, P
    Cavallari, M
    Bonanno, S
    Garaventa, G
    Barbieri, M
    Giaretti, W
    TUMORI, 2000, 86 (01) : 53 - 58
  • [9] The significance of anemia in squamous cell head and neck cancer treated with surgery and postoperative radiotherapy
    van de Pol, SMG
    Doornaert, PAH
    de Bree, R
    Leemans, CR
    Slotman, BJ
    Langendijk, JA
    ORAL ONCOLOGY, 2006, 42 (02) : 131 - 138
  • [10] Early Recurrence in Patients Treated with Surgical Resection and Postoperative Radiotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck
    Abumansour, K.
    Wilke, D. R.
    Kim, M.
    Caissie, A. L.
    Best, L. R.
    Rajaraman, M.
    Hollenhorst, H.
    Snow, S.
    Rigby, M.
    Taylor, S. M.
    Trites, J.
    Lamond, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E729 - E729